Document:

Unassociated Document

    

      Exhibit
        10.2

      Hana
        Biosciences, Inc.

      Stock
        Option Agreement

      (Non-Statutory)

       

      This
        Stock Option Agreement is made and entered into as of the [   ] day of
        [   ], 20[   ], between [   
  ] (“Employee”)
        and
        Hana Biosciences, Inc., a Delaware corporation (the “Company”).

       

      Background

       

      A.  Employee
        has been hired to serve as an employee of the Company or the Company desires
        to
        induce Employee to continue to serve the Company as an employee.

       

      B.  The
        Company has adopted the 2004 Stock Incentive Plan (the “Plan”)
        pursuant to which shares of common stock of the Company have been reserved
        for
        issuance under the Plan.

       

      NOW,
        THEREFORE, the parties hereto agree as follows:

       

      1.  Incorporation
        by Reference.
        The
        terms and conditions of the Plan, a copy of which has been delivered to
        Employee, are hereby incorporated herein and made a part hereof by reference
        as
        if set forth in full. In the event of any conflict or inconsistency between
        the
        provisions of this Agreement and those of the Plan, the provisions of the
        Plan
        shall govern and control.

       

      2.  Grant
        of Option; Purchase Price.
        Subject
        to the terms and conditions herein set forth, including without limitation,
        the
        terms of Paragraph 5, below, the Company hereby irrevocably grants from the
        Plan
        to Employee the right and option, hereinafter called the “Option,”
to
        purchase all or any part of an aggregate of the number of shares of common
        stock, $.001 par value, of the Company (the “Shares”)
        set
        forth at the end of this Agreement after “Number
        of Shares:”
at
        the
        price per Share set forth at the end of this Agreement after “Purchase
        Price:”.

       

      3.  Exercise
        and Vesting of Option.
        Subject
        to the terms and conditions of Paragraph 5, the Option shall be exercisable
        only
        to the extent that all, or any portion thereof, has vested in the Employee.
        Except as provided herein in Paragraph 4, the Options shall vest in Employee
        in
[    
        ] installments
        of
        [     ]
        percent ([    
        ]%)
        of the
        total grant beginning on the first anniversary of the date of this Agreement,
        with an additional [     ]
        percent ([    
        ]%)
        of
        the
        total grant becoming exercisable on each of the next [    
]
        successive anniversaries
        of such
        date, so long as Employee remains an employee of the Company (each such date
        is
        hereinafter referred to singularly as a “Vesting
        Date”
and
        collectively as “Vesting
        Dates”).
        

       

      4. Termination
        of Employment.
        In the
        event that the Employee ceases to be employed by the Company, for any reason
        or
        no reason, with or without cause, prior to any Vesting Date, that part of
        the
        Option scheduled to vest on such Vesting Date, and all parts of the Option
        scheduled to vest in the future, shall not vest and all of Employee's rights
        to
        and under such non-vested parts of the Option shall terminate.

       

      5.
         Term
        of Option.
        To the
        extent vested, and except as otherwise provided in this Agreement, the Option
        shall be exercisable for ten (10) years from the date of this Agreement;
        provided, however, that in the event Employee ceases to be employed by the
        Company, for any reason or no reason, with or without cause, Employee or
        his/her
        legal representative shall have ninety (90) days from the date of such
        termination of his/her position as an employee to exercise any part of the
        Option vested pursuant to Section 3 of this Agreement. Upon the expiration
        of
        such ninety (90) day period, or, if earlier, upon the expiration date of
        the
        Option as set forth above, the Option shall terminate and become null and
        void.

       

      
        
           

        

        
           

          
            

          

        

        
           

        

         

      

      6. Rights
        as Stockholder .
        Employee, as holder of the Option, shall not have any of the rights of a
        stockholder with respect to the Shares covered by the Option except to the
        extent that one or more certificates for such Shares shall be delivered to
        him
        or her upon the due exercise of all or any part of the Option.

       

      7. Transferability.
        The
        Option shall not be transferable except to the extent permitted by the
        Plan.

       

      8. Securities
        Law Matters.
        Employee acknowledges that the Shares to be received by him or her upon exercise
        of the Option may have not been registered under the Securities Act of 1933
        or
        the Blue Sky laws of any state (collectively, the “Securities
        Acts”).
        If
        such Shares have not been so registered, Employee acknowledges and understands
        that the Company is under no obligation to register, under the Securities
        Acts,
        the Shares received by him or her or to assist him or her in complying with
        any
        exemption from such registration if he or she should at a later date wish
        to
        dispose of the Shares. Employee acknowledges that if not then registered
        under
        the Securities Acts, the Shares shall bear a legend restricting the
        transferability thereof, such legend to be substantially in the following
        form:

       

      “The
        shares represented by this certificate have not been registered or qualified
        under federal or state securities laws. The shares may not be offered for
        sale,
        sold, pledged or otherwise disposed of unless so registered or qualified,
        unless
        an exemption exists or unless such disposition is not subject to the federal
        or
        state securities laws, and the Company may require that the availability
        or any
        exemption or the inapplicability of such securities laws be established by
        an
        opinion of counsel, which opinion of counsel shall be reasonably satisfactory
        to
        the Company.”

       

      9. Employee
        Representations.
        Employee hereby represents and warrants that Employee has reviewed with his
        or
        her own tax advisors the federal, state, and local tax consequences of the
        transactions contemplated by this Agreement. Employee is relying solely on
        such
        advisors and not on any statements or representation of the Company or any
        of
        its agents. Employee understands that he or she will be solely responsible
        for
        any tax liability that may result to him or her as a result of the transactions
        contemplated by this Agreement. The Option, if exercised, will be exercised
        for
        investment and not with a view to the sale or distribution of the Shares
        to be
        received upon exercise thereof.

       

      10. Notices.
        All
        notices and other communications provided in this Agreement will be in writing
        and will be deemed to have been duly given when received by the party to
        whom it
        is directed at the following addresses:

       

      
        	
                If
                  to the Company:

              	
                If
                  to Employee:

              
	
                Hana
                  Biosciences, Inc.

                Attn:
                  Chief Financial Officer 

                7000
                  Shoreline Ct, Suite 370

                South
                  San Francisco, CA 94080

              	
                
_______________________________________

                _______________________________________

                 

              

      

      

      
        
           

        

        
           

          
            

          

        

        
           

        

      

       

      11. General.
        

       

      (a)  The
        Option is granted pursuant to the Plan and is governed by the terms thereof.
        The
        Company shall at all times during the term of the Option reserve and keep
        available such number of Shares as will be sufficient to satisfy the
        requirements of this Option Agreement. 

       

      (b)  Nothing
        herein expressed or implied is intended or shall be construed as conferring
        upon
        or giving to any person, firm, or corporation other than the parties hereto,
        any
        rights or benefits under or by reason of this Agreement.

       

      (c)  Each
        party hereto agrees to execute such further documents as may be necessary
        or
        desirable to effect the purposes of this Agreement.

       

      (d)  This
        Agreement may be executed in any number of counterparts, each of which shall
        be
        deemed an original, but all of which shall constitute one and the same
        agreement.

       

      (e)  This
        Agreement, in its interpretation and effect, shall be governed by the laws
        of
        the State of Delaware applicable to contracts executed and to be performed
        therein.

       

      IN
        WITNESS WHEREOF, the undersigned have executed this Agreement as of the date
        first written above.

       

      
        	
                Number
                  of Shares: ___________________

                Exercise
                  Price:      $
                  /share                                 
                  

              	
                EMPLOYEE:

                ________________________________________

                Name:
                  _________________________________________

              
	 	
                 

                HANA
                  BIOSCIENCES, INC.

                ______________________________________________

                Title:
                  __________________________________________Unassociated Document

    Exhibit
      10.27

     

    AMENDMENT
      NO. 2 TO

     

    LICENSE
      AND DEVELOPMENT AGREEMENT

     

    THIS
      AMENDMENT NO. 2 TO LICENSE AND DEVELOPMENT AGREEMENT
      (this
“Amendment”),
      dated
      as of May 15, 2006, is entered into by and between NovaDel
      Pharma, Inc.,
      a
      Delaware corporation (“NovaDel”),
      and
Hana
      Biosciences, Inc.,
      a
      Delaware corporation (the “Licensee”).
      NovaDel and Licensee each may be referred to herein individually as a
“Party,”
or
      collectively as the “Parties.”

    

    WHEREAS,
      the
      Parties entered into that certain License and Development Agreement dated
      October 26, 2004, as amended on August 8, 2005 (the “Agreement”),
      pursuant to which Licensee licensed from NovaDel certain exclusive rights to
      develop and commercialize a pharmaceutical product containing ondansetron as
      an
      active ingredient that will be administered to humans using the Technology
      on
      the terms and conditions set forth in the Agreement; 

    

    WHEREAS,
      the
      Agreement provided that NovaDel would retain rights to certain “Information and
      Inventions” (as such terms are defined in the Agreement) conceived or developed
      following the date of the Agreement; 

    

    WHEREAS,
      the
      terms Information and Invention were not limited in scope to merely information
      and inventions relating to the Licensed Process, Licensed Product(s) or Licensed
      Technology, but to any information or inventions subsequently discovered by
      the
      parties, even if outside the scope of the Agreement; and

    

    WHEREAS,
      the
      parties desire to amend the Agreement to clarify the parties’ intentions with
      regard to the meanings of the terms Information and Inventions.

    

    NOW,
      THEREFORE, in
      consideration of the foregoing premises, the mutual promises and covenants
      of
      the Parties contained herein, and other good and valuable consideration, the
      receipt and sufficiency of which are hereby acknowledged, the Parties hereto,
      intending to be legally bound, do hereby agree as follows:

    

    1.  Definition
      of Information and Inventions.
      Section
      1.5 of the Agreement shall be amended and restated in its entirety to provide
      as
      follows:

     

    “1.25 “Information
      and Inventions”
shall
      mean all technical, scientific and other know-how and information, trade
      secrets, knowledge, technology, means, methods, processes, practices, formulas,
      instructions, skills, techniques, procedures, experiences, ideas, technical
      assistance, designs, drawings, assembly procedures, computer programs,
      apparatuses, specifications, data, results and other material, including
      pre-clinical and clinical trial results, manufacturing procedures and test
      procedures and techniques, (whether or not confidential, proprietary, patented
      or patentable) in written, electronic or any other form now known or hereafter
      developed, and all Improvements, whether to the foregoing or otherwise, and
      other discoveries, developments, inventions, and other intellectual property
      (whether or not confidential, proprietary, patented or patentable), in each
      case, to the extent related to Licensed Process, Licensed Product(s) or Licensed
      Technology.”

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    

    2.  Ownership
      of Information and Inventions.
      Section
      6.1 of the Agreement shall be amended and restated in its entirety to provide
      as
      follows:

     

    “6.1 Ownership
      of Information and Inventions. Subject
      to Section 6.2 and the license grants under Article 2, as between the Parties,
      NovaDel shall own and retain all right, title and interest in and to any and
      all: (a) Information and Inventions that are conceived, discovered, developed
      or
      otherwise made by or on behalf of either Party (or its Affiliates or its
      Sublicensees), whether or not patented or patentable, and any and all Patent
      and
      other intellectual property rights with respect thereto; and (b) other
      Information and Inventions, and Patent and other intellectual property rights
      with respect thereto, that are Controlled (other than pursuant to the license
      grants set forth in Article 2) by either Party, its Affiliates or
      Sublicensees.
      Subject
      to the license grants to Licensee under Article 2, as between the Parties,
      NovaDel shall own and retain all right, title and interest in and to all
      Licensed Technology.”

     

    3.  Confirmation
      of Agreement.
      Except
      as otherwise amended or modified hereby, all terms of the Agreement shall remain
      in full force and effect.

     

    4.  Capitalized
      Terms.
      Capitalized terms used but not defined in this Amendment shall have the meanings
      ascribed to them in the Agreement.

     

    5.  Counterparts.
      This
      Amendment may be executed in one or more counterparts, each of which shall
      be
      deemed an original but all of which taken together shall constitute one and
      the
      same instrument.

     

    IN
      WITNESS WHEREOF,
      the duly
      authorized officers of the Parties have executed this Agreement as of the dates
      set forth below their respective signatures.

    

     

    
      
        	NOVADEL
                PHARMA INC.	HANA
                BIOSCIENCES, INC.
	 	 
	 	 
	
                By:
                  /s/
                  Barry Cohen

              	
                By:
                  /s/
                  Fred Vitale

              
	 	 
	
                Name:
                  Barry Cohen

              	
                Name:
                  Fred
                  Vitale

              
	 	 
	
                Title:
                  Vice President, Business Development

              	
                Title:
                  VP
                  & CBO

              
	 	 
	
                Date:
                  5-15-06

              	
                Date:
                  5-15-06

              

      

    
      
         

      

        2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00120-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00120-of-00352.parquet"}]]